Extrahepatic expression and regulation of protein C in the mouse

American Journal of Pathology

Volumn 153, Issue 2, 1998, Pages 547-555

  Yamamoto, Koji ^a   Loskutoff, David J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; ENDOTOXIN; MESSENGER RNA; PROCOAGULANT; PROTEIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; EPIDIDYMIS; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY TUBULE EPITHELIUM; LIVER; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PURKINJE CELL; PYRAMIDAL NERVE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPERMATOCYTE; TESTIS;

EID: 0031829165     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65597-6     Document Type: Article

References (60)

1. Kisiel W: Human plasma protein C. Isolation, characterization and mechanism of activation by α-thrombin. J Clin Invest 1979, 64:761-769
2. Esmon CT: The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989, 264:4743-4746
3. Marlar RA, Kleiss AJ, Griffin JH: Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982, 59:1067-1072
4. Bajzar L, Manuel R, Nesheim ME: Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 1995, 270:14477-14484
5. van Hinsbergh VWM, Bertina RM, van Wijngaarden A, van Tilburg NH, Emeis JJ, Haverkate F: Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood 1985, 65:444-451
6. Sakata Y, Loskutoff DJ, Gladson CL, Hekman CM, Griffin JH: Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor Blood 1986, 68:1218-1223
7. Seligsohn U, Berger A, Abend M, Rubin L, Attias D, Zivelin A, Rapaport SI: Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984, 310:559-562
8. Bovill EG, Bauer KA, Dickerman JD, Callas P, West B: The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 1989, 73:712-717
9. Kurosawa-Ohsawa K, Kimura M, Kume-Iwaki A, Tanaka T, Tanaka S: Anti-protein C monoclonal antibody induces thrombus in mice. Blood 1990, 75:2156-2163
10. Taylor FB, Chang A Jr, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE: Protein C prevents the coagulopathic, and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987, 79:918-925
11. Gerson WT, Dickerman JD, Bovill EG, Golden E: Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: treatment with protein C concentrate. Pediatrics 1993, 91:418-422
12. Beckmann RJ, Schmidt RJ, Santerre RF, Plutzky J, Crabtree GR, Long GL: The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs. Nucleic Acids Res 1985, 13:5233-5247
13. Okafuji T, Maekawa K, Nawa K, Marumoto Y: The cDNA cloning and mRNA expression of rat protein C. Biochim Biophys Acta 1992, 1131:329-332
14. Jamison CS, McDowell SA, Marlar RA, Friezner Degen SJ: Developmental expression of protein C and protein S in the rat. Thromb Res 1995, 78:407-419
15. Esmon CT: The regulation of natural anticoagulant pathways. Science 1987, 235:1348-1352
16. He X, Shen L, Bjartell A, Malm J, Lilja H, Dahlback B: The gene encoding vitamin K-dependent anticoagulant protein C is expressed in human male reproductive tissues. J Histochem Cytochem 1987, 235:1348-1352
17. Malm J, He X, Bjartell A, Shen L, Dahlback B: Synthesis of vitamin K-dependent protein S in the Leidig cells of human testis. Biochem J 1994, 302:845-850
18. Laurell M, Christensson A, Abrahamsson P, Stenflo J, Lilja H: Protein C inhibitor in human body fluids: seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 1992, 89:1094-1101
19. Radtke K-P, Fernández JA, Greengard JS, Tang WW, Wilson CB, Loskutoff DJ, Scharrer I, Griffin JH: Protein C inhibitor is expressed in tubular cells of human kidney. J Clin Invest 1994, 94:2117-2124
20. Wang AM, Doyle MV, Mark DF: Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 1989, 86:9717-9721
21. Yamamoto K. Loskutoff DJ: Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest 1996, 97:2440-2451
22. Theofilopoulos AN, Dixon FJ: Murine models of systemic lupus erythematosus. Adv Immunol 1985, 37:269-330
23. Hummel KP, Dickie MM, Coleman DL: Diabetes, a new mutation in the mouse. Science 1966, 153:1127-1128
24. Coleman DL, Hummel KP: Studies with the mutation, diabetes, in the mouse. Diabetologia 1967, 3:238-248
25. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
26. Samad F, Yamamoto K, Loskutoff DJ: Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo: induction by tumor necrosis factor-α and lipopolysaccharide. J Clin Invest 1996, 97:37-46
27. Tada N, Sato M, Tsujimura A, Iwase R, Hashimoto-Gotoh T: Isolation and characterization of a mouse protein C cDNA. J Biochem 1992, 111:491-495
28. Tokunaga K, Taniguchi H, Yoda K, Shimizu M, Sakiyama S: Nucleotide sequence of a full-length cDNA for mouse cytoskeletal β-actin mRNA. Nucleic Acids Res 1986, 14:2829
29. Keeton M, Eguchi Y, Sawdey M, Ahn C, Loskutoff DJ: Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am J Pathol 1993, 142:59-70
30. Tanabe S, Sugo T, Matsuda M: Synthesis of protein C in human umbilical vein endothelial cells. J Biochem 1991, 109:924-928
31. Datta SK: Murine lupus. Methods Enzymol 1988, 162:385-412
32. Like AA, Lavine RL, Poffenbarger PL, Chick WL: Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria. Am J Pathol 1972, 66:193-204
33. Cohen MP, Clements RS, Hud E, Cohen JA, Ziyadeh FN: Evolution of renal function abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy. Exp Nephrol 1996, 4:166-171
34. Long GL, Belagaje RM, MacGillivray RTA: Cloning and sequencing of liver cDNA coding for bovine protein C. Proc Natl Acad Sci USA 1984, 81:5653-5656
35. Stief TW, Radtke K, Heimburger N: Inhibition of urokinase by protein C-inhibitor (PCI): evidence for identity of PCI and plasminogen activator inhibitor 3 (PAI 3). Biol Chem Hoppe-Seyler 1987, 368:1427-1433
36. Sappino A-P, Huarte J, Vassalli J-D, Belin D: Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J Clin Invest 1991, 87:962-970
37. He X, Shen L, Bjartell A, Dahlback B: The gene encoding vitamin K-dependent anticoagulant protein S is expressed in multiple rabbit tissues as demonstrated by Northern blotting, immunocytochemistry and in situ hybridization. J Histochem Cytochem 1995, 43:85-96
38. Yasuda F, Hayashi T, Tanitame K, Nishioka J, Suzuki K: Molecular cloning and functional characterization of rat plasma protein S. J Biochem 1995, 117:374-383
39. Dihanich M, Kasser M, Reinhard E, Cunningham D, Monard D: Prothrombin mRNA is expressed by cells of the nervous system. Neuron 1991, 6:575-581
40. Wong VLY, Hofman FM, Ishii H, Fisher M: Regional distribution of thrombomodulin in human brain. Brain Res 1991, 556:1-5
41. Sappino A-P, Madani R, Huarte J, Belin D, Kiss JZ, Wohlwend A, Vassalli J-D: Extracellular proteolysis in the adult murine brain. J Clin Invest 1993, 92:679-685
42. Seeds NW, Williams BL, Bickford PC: Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning. Science 1995, 270:1992-1994
43. Kant KS, Pollak VE, Weiss MA, Glueck HI, Miller MA, Hess EV: Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine 1981, 60:71-86
44. Viberti G, Wiseman MJ, Pinto JR, Messent J: Diabetic nephropathy. Joslin's Diabetes Mellitus. Edited by CR Kahn, GC Weir. Philadelphia, Lea & Febiger, 1994, pp 691-737
45. Tsumagari T, Tanaka K: Effects of fibrinogen degradation products on glomerular mesangial cells in culture. Kidney Int 1984, 26:712-718
46. Faioni EM, Franchi F, Krachmalnicoff A, Valsecchi C, Vigano G, Remuzzi G, Mannucci PM: Low levels of the anticoagulant activity of protein C in patients with chronic renal insufficiency: an inhibitor of protein C is present in uremic plasma. Thromb Haemostasis 1991, 66:420-425
47. Sorensen PJ, Knudsen F, Nielsen AH, Dyerberg J: Protein C assays in uremia. Thromb Res 1989, 54:301-310
48. Cosio FG, Harker C, Batard MA, Brandt JT, Griffin JH: Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria. J Lab Clin Med 1985, 106:218-222
49. Mannucci PM, Valsecchi C, Bottasso B, D'Angelo A, Casati S, Ponticelli C: High plasma levels of protein C activity and antigen in the nephrotic syndrome. Thromb Haemostasis 1986, 55:31-33
50. Hesselvik JF, Malm J, Dahlback B, Blomback M: Protein C, protein S, and C4b-binding protein in severe infection, and septic shock. Thromb Haemostasis 1991, 65:126-129
51. Fijnvandraat K, Derkx B, Peters M, Bijlmer R, Sturk A, Prins MH, van Deventer SJH, ten Cate JW: Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality. Thromb Haemostasis 1995, 73:15-20
52. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU: Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987, 79:124-130
53. Sawdey M, Podor TJ, Loskutoff DJ: Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells: induction by transforming growth factor-β, lipopolysaccharide, and tumor necrosis factor-α. J Biol Chem 1989, 264:10396-10401
54. Mackman N, Sawdey MS, Keeton MR, Loskutoff DJ: Murine tissue factor gene expression in vivo: tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol 1993, 143:76-84
55. Collen D, Rijken DC, Van Damme J, Billiau A: Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivo. Thromb Haemostasis 1982, 48:294-296
56. Conway EM, Rosenberg RD: Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 1988, 8:5588-5592
57. Lentz SR, Tsiang M, Sadler JE: Regulation of thrombomodulin by tumor necrosis factor-α: comparison of transcriptional and posttranscriptional mechanisms. Blood 1991, 77:542-550
58. Boswell JM, Yui MA, Burt DW, Kelley VE: Increased tumor necrosis factor and IL-1β gene expression in the kidneys of mice with lupus nephritis. J Immunol 1988, 141:3050-3054
59. Brennan DC, Yui MA, Wuthrich RP, Kelley VE: Tumor necrosis factor and IL-1 in New Zealand Black/White mice: enhanced gene expression and acceleration of renal injury. J Immunol 1989, 143:3470-3475
60. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91